Morphine: The Quintessential Opioid

Morphine, named after Morpheus, the Greek god of dreams, remains the “gold standard” against which all other analgesics are measured. Isolated in 1804 by Friedrich Sertürner, it was the first alkaloid ever extracted from a plant—the opium poppy (Papaver somniferum). In the Indian context, Morphine is more than just a medication; it is a substance with deep colonial roots, a critical tool in palliative care, and a highly controlled narcotic that represents the apex of the opioid pyramid.

This fourth installment of our 50-part series provides a comprehensive clinical and social analysis of Morphine in India for 2026.

---

1. Substance Profile & Classification

• Generic Name: Morphine Sulfate / Morphine Hydrochloride
• Chemical Class: Natural Opium Alkaloid (Phenanthrene)
• Therapeutic Class: Potent opioid analgesic
• Indian Legal Status:
  • Essential Narcotic Drug (END): Classified under the 2014 Amendment to the NDPS Rules, which simplified the licensing process for “Recognized Medical Institutions” (RMIs) to stock Morphine for palliative care.
  • NDPS Act Status: Strictly regulated under the Narcotic Drugs and Psychotropic Substances Act, 1985. Possession without a valid “Essential Narcotic Drug” prescription is a non-bailable offense.
  • Schedule H1: Requires mandatory record-keeping and a blue-colored prescription in many Indian states for tracking.

---

2. Market Availability and Pricing in India (May 2026)

Morphine is primarily available as immediate-release (IR) tablets, sustained-release (SR) tablets, and injections. It is strictly an institutional drug.

A. PMBJP (Jan Aushadhi Kendra) Availability

❌ Morphine is NOT available in Jan Aushadhi Kendras. The storage requirements (double-lock steel safes) and the “Form 3C” procurement rules for Essential Narcotic Drugs (ENDs) make it incompatible with the PMBJP retail model.

B. Institutional and RMI Prices

Procurement is restricted to hospitals with Recognized Medical Institution (RMI) status.

Brand Name	Manufacturer	Strength/Form	Approx. Clinical Cost (INR)
R-Morph	Rusan Pharma	10mg IR (10 Tabs)	₹125.00
R-Morph SR	Rusan Pharma	30mg SR (10 Tabs)	₹310.00
MST Continus	Modi-Mundipharma	10mg SR (10 Tabs)	₹145.00
Vernit	Veritaz Healthcare	10mg IR (10 Tabs)	₹132.00
Morphine Inj	Neon Laboratories	10mg/1ml Ampoule	₹35.00
Morphine Inj	Veritaz	15mg/1ml Ampoule	₹48.00

[!IMPORTANT] Palliative Access: In 2026, the NPPA ensures that the ceiling price for Morphine remains low to support end-of-life care. However, patients often pay a “dispensation fee” at private RMIs which includes the cost of specialized clinical monitoring.

---

3. Clinical Pharmacology

Mechanism of Action

Morphine acts as a potent agonist at the μ (mu)-opioid receptors in the central nervous system (CNS). It also has some affinity for the κ (kappa) and δ (delta) receptors.

• Inhibition of Ascending Pathways: It blocks the transmission of pain signals from the periphery to the brain.
• Activation of Descending Pathways: It stimulates the brain’s natural pain-modulation systems.
• Emotional Component: Morphine changes the perception of pain; the patient may still feel the pain but no longer finds it distressing.

Pharmacokinetics & Metabolism

• The First-Pass Effect: When taken orally, Morphine undergoes extensive metabolism in the liver. Only about 20-30% of the drug reaches the systemic circulation. This is why oral doses are significantly higher than injectable doses.
• Active Metabolites:
  1. Morphine-6-glucuronide (M6G): A potent analgesic that contributes significantly to the drug’s effect, especially in patients with renal impairment.
  2. Morphine-3-glucuronide (M3G): This metabolite has no analgesic properties and may actually cause neurotoxicity (agitation, seizures) at very high levels.
• Half-life: Relatively short, approximately 2–4 hours.

---

4. Euphoria, Misuse, and Potency

The “Gold Standard” Euphoria

Morphine is often described by users as the “Ultimate Escape.”

• Euphoria Profile: Deep, heavy sedation, an overwhelming sense of warmth, and a complete disconnection from physical and emotional pain. This is the classic “nod.”
• Histamine Release: Morphine causes the highest histamine release among opioids, leading to the “Morphine Itch” and potential flushing of the skin.
• Potency Comparison:
  • Morphine = 1 (Baseline)
  • Tramadol = 0.1 (10x weaker)
  • Fentanyl = 100 (100x stronger)
  • Tapentadol = 0.4 (2.5x weaker)

Misuse Potential in India

While “diversion” of Morphine from hospitals in India is statistically lower than Tramadol, it is highly sought after by those with severe opioid use disorder (OUD). The shift from pharmaceutical Morphine to “Heroin” (Diacetylmorphine) is a common trajectory in Northern India.

---

5. Critical Risks: Toxicity and the Lethal Dose

A. Respiratory Depression

The primary cause of death in Morphine overdose is respiratory failure. Morphine desensitizes the brainstem to rising levels of Carbon Dioxide ($CO_2$), leading to a cessation of breathing.

B. Toxicity Thresholds

• Opioid-Naive Individual: A dose of 120mg to 200mg orally can be lethal.
• Injectable Lethality: As little as 30mg to 60mg intravenously can cause fatal respiratory arrest in a non-user.
• Tolerance: Chronic users may tolerate doses exceeding 2,000mg per day, highlighting the dangerous elasticity of opioid tolerance.

Overdose Signs (The Opioid Triad)

1. Pinpoint Pupils (Miosis).
2. Unconsciousness (Coma).
3. Respiratory Depression (Bradypnea).

---

6. History and the Indian Context

India’s relationship with Morphine is historical and paradoxical.

• Ghazipur & Neemuch: India is one of the world’s largest legal producers of opium for the global pharmaceutical industry. The government-run Opium and Alkaloid Factories (GOAF) in Ghazipur (established 1820) and Neemuch are the primary sites for extracting Morphine from raw opium.
• The Paradox of Plenty: Despite being a global producer, India has historically had some of the lowest rates of Morphine usage for palliative care, largely due to “Opiophobia” among doctors and draconian NDPS laws. The 2014 amendment was a watershed moment for Indian cancer patients.

---

7. Interactions: The Ayurvedic Intersection

A unique risk in India is the interaction between Morphine and traditional medicines.

• Ashwagandha & Brahmi: These herbs possess sedative properties. Combining them with Morphine can lead to unexpected levels of CNS depression.
• Alcohol: The most dangerous interaction. Alcohol increases the rate of release from “Sustained Release” (SR) Morphine tablets (Dose Dumping), leading to a fatal surge of the drug.

---

8. Addiction and Recovery in India

Morphine addiction requires specialized medical intervention.

• Withdrawal Symptoms: Severe abdominal cramps, “Cold Turkey” (goosebumps), lacrimation (tearing), and intense agitation.
• De-addiction Resources:
  • NIMHANS Bangalore: Offers a dedicated Opioid Substitution Therapy (OST) program.
  • AIIMS NDDTC: Provides Buprenorphine and Methadone maintenance.
  • National Helpline: 14446 (Ministry of Social Justice and Empowerment).

---

9. Harm Reduction Strategies

• The “One-at-a-Time” Rule: Never use Morphine alone. If an overdose occurs, no one will be there to administer Naloxone.
• Naloxone Availability: In India, Naloxone is a prescription drug. Family members of palliative care patients should be trained in its use.
• Constipation Management: “The hand that writes the Morphine prescription must write the laxative prescription.” Chronic Morphine usage causes severe Opioid-Induced Constipation (OIC).

---

Next in the Series: Part 5: Fentanyl – The Microgram Menace and the 100x Potency

Disclaimer: This series is for educational and harm-reduction purposes only. Morphine is a strictly controlled substance. Illegal possession is a serious crime under the NDPS Act.